Clinical Trial – Safety and Pharmacokinetic Study of Intravenous Ibuprofen – Fever

The primary objective of this study is to evaluate the pharmacokinetic profile of a single dose of intravenous ibuprofen administered over approximately ten (10) minutes.


Study Type: Interventional  (Clinical Trial)
Estimated Enrollment: 24 participants
Allocation: Single Group Assignment
Intervention Model: Multi-center, Open-label
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Multi-Center, Open-Label Pharmacokinetic and Safety Study for Reduction in Fever or Management of Pain in Pediatric Subjects Aged Birth to Six Months
Actual Study Start Date: July 17, 2017
Estimated Primary Completion Date: December 2018
Estimated Study Completion Date: December 2018



Contact: Byron Kaelin 615-255-0068 ext 250 [email protected]
Contact: Jerry Fox 615-255-0068 ext 226 [email protected] Identifier: NCT02583399


For enrollment please visit

Leave a Reply